A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib

Rheumatoid arthritis-related interstitial pneumonia with a usual interstitial pneumonia (RA-UIP) has a poor prognosis and a new treatment strategy is required. The antifibrotic agent nintedanib reduces the annual rate of decline in forced vital capacity (FVC) in idiopathic pulmonary fibrosis (IPF) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakuwa, Tamaki, Izumi, Shinyu, Sakamoto, Keita, Suzuki, Tomoyuki, Iikura, Motoyasu, Sugiyama, Haruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260442/
https://www.ncbi.nlm.nih.gov/pubmed/30533376
http://dx.doi.org/10.1016/j.rmcr.2018.10.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260442/
https://www.ncbi.nlm.nih.gov/pubmed/30533376
http://dx.doi.org/10.1016/j.rmcr.2018.10.026

Ejemplares similares